START Midwest — Grand Rapids, Michigan

Public research footprint of START Midwest, compiled from the ClinicalTrials.gov public registry.

224

Registered studies

129

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Advanced Solid Tumor · mCRPC (Metastatic Castration-resistant Prostate Cancer) · Advanced Solid Tumors · Colorectal Cancer

Recently updated registry entries

NCT07469891 — A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms (Recruiting)
NCT05067283 — A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001) (Recruiting)
NCT04811560 — A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1) (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at START Midwest?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.